Trulicity Market Size & Share Analysis - Growth Trends and Forecast (2027 - 2032)

The Trulicity Market Report is Segmented by Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and Latin America). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Trulicity Market Size and Share

Trulicity Market Size
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Benchmark Trulicity Against Other Healthcare Markets

Trulicity Market Analysis by Mordor Intelligence

The Trulicity Market size was valued at USD 10.36 billion in 2026 and is estimated to grow from USD 11.35 billion in 2027 to reach USD 17.91 billion by 2032, at a CAGR of 9.55% during the forecast period (2027-2032).

The Centers for Disease Control (CDC) determined that COVID-19 was a serious public health threat for people with serious chronic diseases, including diabetes. People with diabetes were more likely to experience complications when infected with the virus. As per the American Diabetes Association, people with diabetes, if uncontrolled, had worse outcomes if infected with a virus such as COVID-19. The International Diabetes Federation explained that when people with diabetes develop a viral infection, it can be harder to treat due to fluctuations in blood glucose levels and diabetes complications as the immune system is compromised, making it harder to fight the virus and likely leading to a longer recovery period.

Further, during the COVID-19 pandemic, many restrictions were imposed, putting people into lockdown, which led to contribution to obesity through unhealthy diets, physical inactivity, or highly sedentary behaviors. Further, these factors were associated with sustained weight gain and persisted even after lockdown restrictions were lifted. Weight management guidelines recommended a multi-component approach for weight loss in patients living with obesity and overweight. The use of anti-obesity medications was an effective option for weight control to improve the quality of life and prevent the progression of weight-related comorbidities.

Trulicity is an injectable diabetes medicine that helps control blood sugar levels. Trulicity is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It is also used to help reduce the risk of serious heart problems such as heart attack or stroke in adults who have type-2 diabetes and heart disease. It is used for adults and children 10 years of age and older with type-2 diabetes, along with diet and exercise to improve blood sugar.

Designed to reshape global care networks over the next decade, the 2022 World Health Assembly Resolution establishes a legally backed framework for systemic diabetes intervention. The mandate directs member countries to transition diabetes prevention and management directly into primary healthcare models while removing economic barriers to scale up universal insulin access. Structurally, it prioritises the international harmonization of regulatory policies for metabolic pharmaceuticals and monitoring tech, paired with modernized data surveillance frameworks.

Major factors that are expected to boost the growth of the studied market in the forecast period are rising obesity and inactivity rates among people, which have resulted in an increase in the diabetes population over time, a rise in the sedentary lifestyle, improper dietary patterns, and the inherent history of diabetes disorders. In addition, rising investment in research and development, technological developments, and new product launches will further provide potential opportunities for the growth of glucagon-like peptide 1 (GLP-1) agonists such as Trulicity in the coming years.

Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.

Competitive Landscape

Market Concentration

Trulicity Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

The Trulicity Market is consolidated with no generic products.

Trulicity Industry Leaders

  1. Eli Lilly

  2. *Disclaimer: Major Players sorted in no particular order

Trulicity Market Companies Covered in this Report

  • Eli Lilly and Company

Read Analysis of Trulicity Companies

Recent Industry Developments in Trulicity Market

  • November 2023: Eli Lilly New Zealand expected limited availability of the type-2 Diabetes (T2D) medication Trulicity (dulaglutide) due to global supply pressure. The company is focused on maintaining supplies of Trulicity in New Zealand for existing patients. The supply situation is expected to continue to remain dynamic until the end of 2024. During this time, patients in New Zealand may experience delays or interruptions in fulfilling their Trulicity prescriptions.
  • July 2023: Eli Lilly has informed the Therapeutic Goods Administration (TGA) that the limited availability of Trulicity (dulaglutide) will be extended to 31 December 2024, in line with a similar notification for Ozempic (semaglutide).

Table of Contents for Trulicity Industry Report

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Trulicity
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.1.1 United States
    • 5.2.1.2 Canada
    • 5.2.1.3 Rest of North America
    • 5.2.2 Europe
    • 5.2.2.1 Germany
    • 5.2.2.2 Spain
    • 5.2.2.3 Italy
    • 5.2.2.4 France
    • 5.2.2.5 United Kingdom
    • 5.2.2.6 Russia
    • 5.2.2.7 Rest of Europe
    • 5.2.3 Asia-Pacific
    • 5.2.3.1 Japan
    • 5.2.3.2 China
    • 5.2.3.3 Australia
    • 5.2.3.4 India
    • 5.2.3.5 South Korea
    • 5.2.3.6 Malaysia
    • 5.2.3.7 Indonesia
    • 5.2.3.8 Thailand
    • 5.2.3.9 Philippines
    • 5.2.3.10 Vietnam
    • 5.2.3.11 Rest of Asia-Pacific
    • 5.2.4 Latin America
    • 5.2.4.1 Brazil
    • 5.2.4.2 Mexico
    • 5.2.4.3 Rest of Latin America
    • 5.2.5 Middle East and Africa
    • 5.2.5.1 South Africa
    • 5.2.5.2 Saudi Arabia
    • 5.2.5.3 Oman
    • 5.2.5.4 Egypt
    • 5.2.5.5 Iran
    • 5.2.5.6 Rest of Middle East and Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 Eli Lilly and Company
  • *List Not Exhaustive

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Global Trulicity Market Report Scope

Trulicity (Dulaglutide) is a medication used for the treatment of type-2 diabetes in combination with diet and exercise. The Trulicity market is segmented by Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). 

The report offers the value (in USD) and volume (in Units) for the above segments.

Segmentation Overview

Geography
Trulicity Market segmentation breakdown
North America United States
Canada
Rest of North America
Europe Germany
Spain
Italy
France
United Kingdom
Russia
Rest of Europe
Asia-Pacific Japan
China
Australia
India
South Korea
Malaysia
Indonesia
Thailand
Philippines
Vietnam
Rest of Asia-Pacific
Latin America Brazil
Mexico
Rest of Latin America
Middle East and Africa South Africa
Saudi Arabia
Oman
Egypt
Iran
Rest of Middle East and Africa
Trulicity Market segmentation breakdown
Geography North America United States
Canada
Rest of North America
Europe Germany
Spain
Italy
France
United Kingdom
Russia
Rest of Europe
Asia-Pacific Japan
China
Australia
India
South Korea
Malaysia
Indonesia
Thailand
Philippines
Vietnam
Rest of Asia-Pacific
Latin America Brazil
Mexico
Rest of Latin America
Middle East and Africa South Africa
Saudi Arabia
Oman
Egypt
Iran
Rest of Middle East and Africa

Key Questions Answered in the Report

How big is the Trulicity Market?

The Trulicity Market size is expected to reach USD 10.36 billion in 2026 and grow at a CAGR of greater than 9.55% to reach USD 17.91 billion by 2032.

What is the current Trulicity Market size?

In 2027, the Trulicity Market size is expected to reach USD 11.35 billion.

Who are the key players in Trulicity Market?

Eli Lilly are the major companies operating in the Trulicity Market.

Which is the fastest growing region in Trulicity Market?

North America is estimated to grow at the highest CAGR over the forecast period (2027-2032).

Which region has the biggest share in Trulicity Market?

In 2026, the North America accounts for the largest market share in Trulicity Market.

Page last updated on: